Literature DB >> 16736423

Minimal change nephropathy in a 7-year-old boy with Rosai-Dorfman disease.

Onur Sakallioglu1, Faysal Gok, Suleyman Kalman, Abdullah Avni Atay, Ayper Kaya, Ali Duzova, Erdal Gokcay.   

Abstract

Rosai-Dorfman (R-D) disease is a benign lympho-histiocytosis of the lymphoid system. Immune derangement due to cytokine over-expression (tumor necrosis factor (TNF), interleukin (IL)-1b and IL-6) has been considered the cause of R-D disease. We present a 7-year-old boy with R-D disease who developed minimal change nephropathy (MCN) during the progression of R-D disease. The patient was resistant to oral prednisolone; and the remission of both R-D disease and MCN was achieved with oral cyclophosphamide (2 mg/kg, 12 weeks). MCN, the most common cause of nephrotic syndrome in childhood, is generally accepted to emerge by way of cytokine derangement. Correlation between R-D disease activity and the development and remission of nephrotic syndrome in our case suggested that nephrotic syndrome had been induced through some R-D disease-related immune mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736423

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  2 in total

Review 1.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

2.  Membranoproliferative glomerulonephritis associated with Rosai-Dorfman disease.

Authors:  Keisuke Sugimoto; Satoshi Ueda; Mitsuru Okada; Tsukasa Takemura
Journal:  Clin Nephrol Case Stud       Date:  2017-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.